Phieng Siliphaivanh

This inventor holds 35 USPTO granted patents and 12 published patent applications, plus 3 CIPO patents and 28 EPO patents, primarily in Cancer Therapeutics. Top assignees: Merck Sharp + Dohme Corp., Merck Sharp & Dohme LLC, Merch Sharp & Dohme Ltd. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Phieng Siliphaivanh. Retrieved from https://idiyas.com/inventor/phieng-siliphaivanh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 35 (Patent Applications = 12)

% Patents Active = 97.1

CIPO Patents = 3 (Patent Applications = 6)

EPO Patents = 28 (Patent Applications = 34)

Average Co-Inventor Count = 9.5

ph-index = 5

Forward Citations = 69(Granted Patents)

Location History:

Brookline, MA (US) (2010 - 2012)
Newtown, MA (US) (2012)
Newton Highland, MA (US) (2015)
Newton, MA (US) (2012 - 2024)

Company Filing History:

31 out of 2,405

Merck Sharp + Dohme Corp.

patents

3 out of 70

Merck Sharp & Dohme LLC

patents

1 out of 4

Merch Sharp & Dohme Ltd

patents

4. 1 out of 9

Msd International Gmbh

patents

5. 1 out of 10

Msd R&d (China) Co., Ltd.

where one patent can have more than one assignee

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

RIPK1 Inhibitors

PRMT5 Inhibitors

ERK Inhibitors

Histone Deacetylase Inhibitors

Cyanomethylpyrazole Carboxamides

Aryl Sulfonamides

Aryl Acylsulfonamides

Antifungal Agents

Disubstituted Aniline Compounds

Benzothiophene Hydroxamic Acid Derivatives

Modified Malonate Derivatives

Heterocyclic Compounds

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12753190 - Spirotricycle RIPK1 inhibitors and methods of uses thereof (2026-10-06),

2. 12643904 - RIPK1 inhibitors and methods of use (2026-06-02),

3. 12595248 - PRMT5 inhibitors (2026-04-07),

4. 12454525 - IL4I1 inhibitors and methods of use (2025-10-28),

5. 12441730 - PRMT5 inhibitors (2025-10-14),

6. 12264139 - Aryl sulfonamides as BLT1 antagonists (2025-04-01),

7. 12180226 - Spirotricycle RIPK1 inhibitors and methods of uses thereof (2024-12-31),

8. 12173026 - PRMT5 inhibitors (2024-12-24),

9. 11993602 - PRMT5 inhibitors (2024-05-28),

10. 10975084 - KDM5 inhibitors (2021-04-13),

11. 10759805 - Compounds that are ERK inhibitors (2020-09-01),

12. 10450309 - Aryl sulfonamides as BLT1 antagonists (2019-10-22),

13. 10370368 - Aryl acylsulfonamides as BLT1 antagonists (2019-08-06),

14. 10336733 - Aryl acylsulfonamides as BLT1 antagonists (2019-07-02),

15. 10065967 - Compounds that are ERK inhibitors (2018-09-04),

Title: Inventor Phieng Siliphaivanh: Revolutionizing Technology in Newton

Introduction: Phieng Siliphaivanh is a visionary inventor based in Newton, MA, known for his groundbreaking contributions to the field of technology.

Latest Patents: Phieng Siliphaivanh holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, with his most recent patent focusing on a cutting-edge energy storage solution.

Career Highlights: With a career spanning over two decades, Phieng Siliphaivanh has worked for leading tech companies, spearheading research and development projects that have led to significant advancements in various industries.

Collaborations: Throughout his career, Phieng Siliphaivanh has collaborated with top researchers, engineers, and scientists from renowned universities and research institutions, fostering a culture of innovation and excellence.

Conclusion: Phieng Siliphaivanh's relentless pursuit of innovation and his passion for creating a sustainable future have solidified his position as a trailblazing inventor in the technology sector.

Profile summary based on public USPTO records.